Related references
Note: Only part of the references are listed.Issues and Questions Surrounding Screening for Cognitive Impairment in Older Patients
Ronald C. Petersen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Screening for Cognitive Impairment in Older Adults US Preventive Services Task Force Recommendation Statement
Douglas K. Owens et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia
Shorena Janelidze et al.
NATURE MEDICINE (2020)
Neuropsychiatric Symptoms in Mild Cognitive Impairment: A Literature Review
Evangelia Martin et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2020)
Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
Marta Mila-Aloma et al.
ALZHEIMERS & DEMENTIA (2020)
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
Sebastian Palmqvist et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Gill Livingston et al.
LANCET (2020)
Healthy lifestyle and the risk of Alzheimer dementia Findings from 2 longitudinal studies
Klodian Dhana et al.
NEUROLOGY (2020)
The dynamics of biomarkers across the clinical spectrum of Alzheimer's disease
Christoforos Hadjichrysanthou et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Is Alzheimer's Disease Risk Modifiable?
Alberto Serrano-Pozo et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
The Alzheimer's Disease Clinical Spectrum Diagnosis and Management
Alireza Atri
MEDICAL CLINICS OF NORTH AMERICA (2019)
Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia
Gil D. Rabinovici et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Current and Future Treatments in Alzheimer's Disease
Alireza Atri
SEMINARS IN NEUROLOGY (2019)
Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders
Eryn L. Werry et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer's Disease and Related Dementias and Strategic Implications for Stakeholders
Youssef H. El-Hayek et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Neuroimaging Biomarkers for Alzheimer's Disease
Freddie Marquez et al.
MOLECULAR NEURODEGENERATION (2019)
The neuropathological diagnosis of Alzheimer's disease
Michael A. DeTure et al.
MOLECULAR NEURODEGENERATION (2019)
Efficacy and Safety of Cholinesterase Inhibitors for Mild Cognitive Impairment: A Systematic Review and Meta-Analysis
Shinji Matsunaga et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Biomarker-Based Signature of Alzheimer's Disease in Pre-MCI Individuals
Elena Chipi et al.
BRAIN SCIENCES (2019)
Blood-based biomarkers for Alzheimer's disease-An update
Henrik Zetterberg
JOURNAL OF NEUROSCIENCE METHODS (2019)
Importance of Treatment Status in Links Between Type 2 Diabetes and Alzheimer's Disease
Elissa C. McIntosh et al.
DIABETES CARE (2019)
Association of long-term adherence to the mind diet with cognitive function and cognitive decline in American women
A. M. Berendsen et al.
JOURNAL OF NUTRITION HEALTH & AGING (2018)
Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
Ronald C. Petersen et al.
NEUROLOGY (2018)
Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
Michelle M. Mielke et al.
ALZHEIMERS & DEMENTIA (2018)
Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States
Ron Brookmeyer et al.
ALZHEIMERS & DEMENTIA (2018)
The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable
David S. Knopman et al.
ALZHEIMERS & DEMENTIA (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Association Between Dementia Severity and Recommended Lifestyle Changes: A Retrospective Cohort Study
Timothy Thoits et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2018)
Molecular biomarkers of Alzheimer's disease: progress and prospects
Tammaryn Lashley et al.
DISEASE MODELS & MECHANISMS (2018)
Amyloid Accumulation and Cognitive Decline in Clinically Normal Older Individuals: Implications for Aging and Early Alzheimer's Disease
Elizabeth C. Mormino et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Dementia Prevalence in the United States in 2000 and 2012: Estimates Based on a Nationally Representative Study
Peter Hudomiet et al.
JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES (2018)
Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications
Geert Jan Biessels et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
Fuyuki Kametani et al.
FRONTIERS IN NEUROSCIENCE (2018)
Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis
Jared M. Campbell et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Questions concerning the role of amyloid-beta in the definition, aetiology and diagnosis of Alzheimer's disease
Gary P. Morris et al.
ACTA NEUROPATHOLOGICA (2018)
Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease
Miia Kivipelto et al.
NATURE REVIEWS NEUROLOGY (2018)
Mild cognitive impairment in primary care: a clinical review
Georges Assaf et al.
POSTGRADUATE MEDICAL JOURNAL (2018)
Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease
Yung-Shuan Lin et al.
SCIENTIFIC REPORTS (2018)
Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health
Jennifer G. Goldman et al.
NPJ PARKINSONS DISEASE (2018)
Mini-Mental State Examination: diagnostic test accuracy study in primary care referrals
Andrew J. Larner
NEURODEGENERATIVE DISEASE MANAGEMENT (2018)
Alzheimer's disease and blood-based biomarkers - potential contexts of use
Martina Zverova
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2018)
Amyloid Imaging: Poised for Integration into Medical Practice
Keshav Anand et al.
NEUROTHERAPEUTICS (2017)
Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis
Lauren M. Byrne et al.
LANCET NEUROLOGY (2017)
Alzheimer's disease prevention: from risk factors to early intervention
Marta Crous-Bou et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Proportion of dementia in Australia explained by common modifiable risk factors
Kimberly Ashby-Mitchell et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
On the path to 2025: understanding the Alzheimer's disease continuum
Paul S. Aisen et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Prevalence and determinants of undetected dementia in the community: a systematic literature review and a meta-analysis
Linda Lang et al.
BMJ OPEN (2017)
A Comparison of the Prevalence of Dementia in the United States in 2000 and 2012
Kenneth M. Langa et al.
JAMA INTERNAL MEDICINE (2017)
Strategies for dementia prevention: latest evidence and implications
Gopalkumar Rakesh et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2017)
Impact of Functional Deficits in Instrumental Activities of Daily Living in Mild Cognitive Impairment: A Clinical Algorithm to Predict Progression to Dementia
Davangere P. Devanand et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2017)
Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic
Sid E. O'Bryant et al.
ALZHEIMERS & DEMENTIA (2017)
Increasing Precision of Clinical Diagnosis of Alzheimer's Disease Using a Combined Algorithm Incorporating Clinical and Novel Biomarker Data
Marwan N. Sabbagh et al.
NEUROLOGY AND THERAPY (2017)
Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis
Vitaliy Ovod et al.
ALZHEIMERS & DEMENTIA (2017)
Computerized Cognitive Training in Older Adults With Mild Cognitive Impairment or Dementia: A Systematic Review and Meta-Analysis
Nicole T. M. Hill et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011-2013
Richard A. Goodman et al.
ALZHEIMERS & DEMENTIA (2017)
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
Bruno Dubois et al.
ALZHEIMERS & DEMENTIA (2016)
Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
Sebastian Palmqvist et al.
BRAIN (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II
F. E. Matthews et al.
NATURE COMMUNICATIONS (2016)
Recent global trends in the prevalence and incidence of dementia, and survival with dementia
Martin Prince et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and Challenges
Bruno Dubois et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Routine cognitive screening in a neurology practice Effect on physician behavior
Michael Rosenbloom et al.
NEUROLOGY-CLINICAL PRACTICE (2016)
Primary Care Physicians Practicing Preventive Medicine in the Outpatient Setting
David Snipelisky et al.
INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE (2016)
Innovative diagnostic tools for early detection of Alzheimer's disease
Christoph Laske et al.
ALZHEIMERS & DEMENTIA (2015)
MIND diet slows cognitive decline with aging
Martha Clare Morris et al.
ALZHEIMERS & DEMENTIA (2015)
Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective
Matthew Baumgart et al.
ALZHEIMERS & DEMENTIA (2015)
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
Kaj Blennow et al.
ALZHEIMERS & DEMENTIA (2015)
A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial
Tiia Ngandu et al.
LANCET (2015)
Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses
Robert Howard et al.
LANCET NEUROLOGY (2015)
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
Sebastian Palmqvist et al.
NEUROLOGY (2015)
A Practical Approach to Dementia in the Outpatient Primary Care Setting
Mark D. Darrow
PRIMARY CARE (2015)
Cumulative, additive benefits of memantine-donepezil combination over component monotherapies in moderate to severe Alzheimer's dementia: a pooled area under the curve analysis
Alireza Atri et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Mild cognitive impairment and its management in older people
Sima Ataollahi Eshkoor et al.
Clinical Interventions in Aging (2015)
Conformation Determines the Seeding Potencies of Native and Recombinant Tau Aggregates
Benjamin Falcon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Mild cognitive impairment: searching for the prodrome of Alzheimer's disease
PAUL B. ROSENBERG et al.
World Psychiatry (2015)
Aβ and cognitive change: Examining the preclinical and prodromal stages of Alzheimer's disease
Yen Ying Lim et al.
ALZHEIMERS & DEMENTIA (2014)
Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease
Yen Ying Lim et al.
BRAIN (2014)
Effect of Physical Exercise on Cognitive Performance in Older Adults with Mild Cognitive Impairment or Dementia: A Systematic Review
Hanna Ohman et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2014)
Public health guidance to facilitate timely diagnosis of dementia: ALzheimer's COoperative Valuation in Europe recommendations
Dawn Brooker et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2014)
The Diagnosis and Management of Mild Cognitive Impairment A Clinical Review
Kenneth M. Langa et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Physical Activity Reduces the Risk of Dementia in Mild Cognitive Impairment Subjects: A Cohort Study
Giulia Grande et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Natural History of Functional Decline in Alzheimer's Disease: A Systematic Review
Fleur Delva et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Harmonized diagnostic criteria for Alzheimer's disease: recommendations
J. C. Morris et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Biomarkers in dementia: clinical utility and new directions
R. M. Ahmed et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
Should the Mini-Mental State Examination be retired?
C. Carnero-Pardo
NEUROLOGIA (2014)
The Evolution of Preclinical Alzheimer's Disease: Implications for Prevention Trials
Reisa Sperling et al.
NEURON (2014)
Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease
Anne M. Fagan et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Mild Cognitive Impairment: Diagnosis, Longitudinal Course, and Emerging Treatments
Jennifer N. Vega et al.
CURRENT PSYCHIATRY REPORTS (2014)
Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting
Cyndy B. Cordell et al.
ALZHEIMERS & DEMENTIA (2013)
Treatment for mild cognitive impairment: systematic review
Claudia Cooper et al.
BRITISH JOURNAL OF PSYCHIATRY (2013)
Risk Factors for the Progression of Mild Cognitive Impairment to Dementia
Noll L. Campbell et al.
CLINICS IN GERIATRIC MEDICINE (2013)
Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
Stephanie J. B. Vos et al.
LANCET NEUROLOGY (2013)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack et al.
LANCET NEUROLOGY (2013)
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
Victor L. Villemagne et al.
LANCET NEUROLOGY (2013)
Validation of the Amsterdam IADL Questionnaire©, a New Tool to Measure Instrumental Activities of Daily Living in Dementia
Sietske A. M. Sikkes et al.
NEUROEPIDEMIOLOGY (2013)
Brain β-amyloid load approaches a plateau
Clifford R. Jack et al.
NEUROLOGY (2013)
New Insights into the Dementia Epidemic
Eric B. Larson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Rate of Conversion from Prodromal Alzheimer's Disease to Alzheimer's Dementia: A Systematic Review of the Literature
Alex Ward et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA (2013)
Influence of Alzheimer Disease Family History and Genetic Risk on Cognitive Performance in Healthy Middle-Aged and Older People
Markus Donix et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2012)
Finding Dementia in Primary Care: The Results of a Clinical Demonstration Project
John Riley McCarten et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2012)
MDS 3.0: Brief Interview for Mental Status
Debra Saliba et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2012)
Validity, Significance, Strengths, Limitations, and Evidentiary Value of Real-World Clinical Data for Combination Therapy in Alzheimer's Disease: Comparison of Efficacy and Effectiveness Studies
Alireza Atri et al.
NEURODEGENERATIVE DISEASES (2012)
Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease
D. S. Knopman et al.
NEUROLOGY (2012)
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
Robert Howard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors
Haythum O. Tayeb et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Mild cognitive impairment and dementia in primary care: the value of medical history
Javier Olazaran et al.
FAMILY PRACTICE (2011)
Evaluation of a Calibrated 18F-FDG PET Score as a Biomarker for Progression in Alzheimer Disease and Mild Cognitive Impairment
Karl Herholz et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
The projected effect of risk factor reduction on Alzheimer's disease prevalence
Deborah E. Barnes et al.
LANCET NEUROLOGY (2011)
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI
Susan M. Landau et al.
NEUROBIOLOGY OF AGING (2011)
Neuropathological Alterations in Alzheimer Disease
Alberto Serrano-Pozo et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
The controversial promises of cholinesterase inhibitors for Alzheimer's disease and related dementias: A qualitative study of caregivers' experiences
Andre Smith et al.
JOURNAL OF AGING STUDIES (2011)
Self-administered Gerocognitive Examination (SAGE) A Brief Cognitive Assessment Instrument for Mild Cognitive Impairment (MCI) and Early Dementia
Douglas W. Scharre et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2010)
Blood-based biomarkers of Alzheimer's disease: challenging but feasible
Madhav Thambisetty et al.
BIOMARKERS IN MEDICINE (2010)
Total and phosphorylated tau protein as biological markers of Alzheimer's disease
Harald Hampel et al.
EXPERIMENTAL GERONTOLOGY (2010)
Quantitative structural MRI for early detection of Alzheimer's disease
Linda K. McEvoy et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Harald Hampel et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies
A. J. Mitchell et al.
ACTA PSYCHIATRICA SCANDINAVICA (2009)
Missed and Delayed Diagnosis of Dementia in Primary Care Prevalence and Contributing Factors
Andrea Bradford et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2009)
Transmission and spreading of tauopathy in transgenic mouse brain
Florence Clavaguera et al.
NATURE CELL BIOLOGY (2009)
Neuropsychiatric symptoms predict change in quality of life of Alzheimer disease patients: A two-year follow-up study
Hiroshi Tatsumi et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2009)
Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study
Martin Steinberg et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2007)
Implementing routine cognitive screening of older adults in primary care: Process and impact on physician behavior
Soo Borson et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2007)
Comparison of the Saint Louis University Mental Status examination and the Mini-Mental State Examination for detecting dementia and mild neurocognitive disorder - A pilot study
Syed H. Tariq et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2006)
Improving identification of cognitive impairment in primary care
S Borson et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2006)
The AD8 - A brief informant interview to detect dementia
JE Galvin et al.
NEUROLOGY (2005)
Assessing age of dementia onset - Validity of informant reports
A Fiske et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2005)
The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment
ZS Nasreddine et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition
OL Lopez et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease
K Rockwood
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
Share Paper
